We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Boston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures.
The WHO updates Emergency Use Listing (EUL) for Novavax's (NVAX) COVID-19 vaccine to include its use as a primary series in adolescents and for use as a booster dose in adults.
Just like identifying stocks with growth potential, pinpointing toxic stocks and offloading them at the right time is crucial to guard one's portfolio from big losses. EBS, WDC, TWKS and DZSI are a few such toxic stocks.
Large-cap stocks are a staple in every portfolio. They're well-established, have greater analyst coverage, typically pay dividends, and help shield investors from volatility.
Investor confidence in Biogen (BIIB) is rattled following reports of a study participant's death who was administered its Alzheimer's disease (AD) antibody in clinical studies.
The FDA accepts Sarepta's (SRPT) regulatory filing seeking accelerated approval for SRP-9001, a gene therapy for DMD indication. A final decision is expected by May 2023.
Merit Medical (MMSI) launches basixALPHA inflation device in the United States for one-handed preparation and fast inflation with minimal exertion to streamline angioplasty procedures.
The latest PMCF study demonstrates that Boston Scientific's (BSX) ACURATE neo2 Aortic Valve System is expected to significantly improve patient outcomes.
Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.
Here we discuss ShockWave Medical (SWAV), iRadimed (IRMD) and Tactile Systems Technology (TCMD), which have the potential to outperform their industry going forward.
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
medical: Archive
Molina Healthcare (MOH) Up 11% in 6 Months: More Room to Run?
by Zacks Equity Research
Molina Healthcare (MOH) is well-poised for growth on growing premiums, membership increases in Government business and sufficient cash reserves.
MOHPositive Net Change CIPositive Net Change AMNNegative Net Change MEDPNegative Net Change
medical
Boston Scientific's (BSX) New Buyout to Expand its Portfolio
by Zacks Equity Research
Boston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures.
BSXNegative Net Change AMNNegative Net Change APENPositive Net Change SWAVNegative Net Change
medical medical-devices
Here's Why You Should Hold on to Nevro (NVRO) Stock Now
by Zacks Equity Research
Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market.
MCKNegative Net Change AMNNegative Net Change NVROPositive Net Change SWAVNegative Net Change
medical medical-devices
Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL
by Zacks Equity Research
The WHO updates Emergency Use Listing (EUL) for Novavax's (NVAX) COVID-19 vaccine to include its use as a primary series in adolescents and for use as a booster dose in adults.
PFENegative Net Change MRNANegative Net Change NVAXNegative Net Change BNTXPositive Net Change
biotechs medical vaccines
Here's Why You Should Retain PerkinElmer (PKI) Stock Now
by Zacks Equity Research
PerkinElmer (PKI) continues to gain from solid product portfolio despite forex woes.
MCKNegative Net Change PKINegative Net Change AMNNegative Net Change SWAVNegative Net Change
medical medical-devices
The Zacks Analyst Blog Highlights Procter & Gamble, Coca-Cola, The Progressive, Zoetis and Palo Alto Networks
by Zacks Equity Research
Procter & Gamble, Coca-Cola, The Progressive, Zoetis and Palo Alto Networks are part of the Zacks top Analyst Blog.
KONegative Net Change PGPositive Net Change PGRNegative Net Change PANWNegative Net Change ZTSPositive Net Change
consumer-staples insurance medical
Do Options Traders Know Something About Novavax (NVAX) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Novavax (NVAX) stock based on the movements in the options market lately.
NVAXNegative Net Change
medical medical-devices
4 Toxic Stocks More So Hazardous Amid Volatile Times
by Rimmi Singhi
Just like identifying stocks with growth potential, pinpointing toxic stocks and offloading them at the right time is crucial to guard one's portfolio from big losses. EBS, WDC, TWKS and DZSI are a few such toxic stocks.
WDCNegative Net Change EBSNegative Net Change DZSIPositive Net Change TWKSPositive Net Change
communications computers medical tech-stocks
Philips (PHG) Showcases New AI-Based Solutions at the RSNA
by Zacks Equity Research
Koninklijke Philips (PHG) banks on its new AI solutions to address issues faced by Radiology experts in the healthcare industry and drive prospects.
PHGPositive Net Change AGENNegative Net Change ABEONegative Net Change ACRSNegative Net Change
artificial-intelligence medical medical-devices
3 Top-Ranked Large-Caps With Big Growth
by Derek Lewis
Large-cap stocks are a staple in every portfolio. They're well-established, have greater analyst coverage, typically pay dividends, and help shield investors from volatility.
ADMNegative Net Change MPCNegative Net Change ELVNegative Net Change
agriculture consumer-staples medical oil-energy
Biogen (BIIB) Down on Report of Death in Alzheimer's Study
by Zacks Equity Research
Investor confidence in Biogen (BIIB) is rattled following reports of a study participant's death who was administered its Alzheimer's disease (AD) antibody in clinical studies.
BIIBPositive Net Change RHHBYPositive Net Change LLYNegative Net Change PRTAPositive Net Change
biotechs medical
Sarepta's (SRPT) DMD Gene Therapy BLA Gets FDA Priority Review
by Zacks Equity Research
The FDA accepts Sarepta's (SRPT) regulatory filing seeking accelerated approval for SRP-9001, a gene therapy for DMD indication. A final decision is expected by May 2023.
RHHBYPositive Net Change VRTXPositive Net Change ANGNNegative Net Change SRPTPositive Net Change
biotechs gene-therapy medical
Here's Why You Should Hold OPKO Health (OPK) Stock For Now
by Zacks Equity Research
OPKO Health (OPK) is likely to gain from the potential in RAYALDEE that targets a growing market coupled with new collaborations and acquisitions.
MCKNegative Net Change AMNNegative Net Change OPKNegative Net Change SWAVNegative Net Change
medical medical-devices
Merit Medical (MMSI) Launches New Inflation Device basixALPHA
by Zacks Equity Research
Merit Medical (MMSI) launches basixALPHA inflation device in the United States for one-handed preparation and fast inflation with minimal exertion to streamline angioplasty procedures.
MCKNegative Net Change MMSIPositive Net Change AMNNegative Net Change SWAVNegative Net Change
medical medical-devices
What You Need to Know From UnitedHealth's (UNH) Latest Outlook
by Zacks Equity Research
UnitedHealth (UNH) expects the top line to be within the range of $357-$360 billion in 2023.
UNHPositive Net Change AMNNegative Net Change IVANegative Net Change ELVNegative Net Change
medical
Factors That Make Elevance Health (ELV) a Lucrative Bet Now
by Zacks Equity Research
Elevance Health (ELV) continues to benefit from sustained top-line growth, higher membership in Government business and a sturdy financial position.
MRKNegative Net Change MEDPNegative Net Change SWAVNegative Net Change ELVNegative Net Change
medical
AmerisourceBergen (ABC) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.
ABCNegative Net Change MCKNegative Net Change AMNNegative Net Change SWAVNegative Net Change
medical medical-devices
Boston Scientific (BSX) Posts Positive Post-Market Study Data
by Zacks Equity Research
The latest PMCF study demonstrates that Boston Scientific's (BSX) ACURATE neo2 Aortic Valve System is expected to significantly improve patient outcomes.
BSXNegative Net Change MCKNegative Net Change AMNNegative Net Change SWAVNegative Net Change
medical medical-devices
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
by Zacks Equity Research
Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.
PFENegative Net Change MRNANegative Net Change NVAXNegative Net Change BNTXPositive Net Change
biotechs medical messenger-rna vaccines
Cigna (CI) Rises 18.9% in 6 Months: More Growth in Store?
by Zacks Equity Research
Cigna (CI) expects its long-term adjusted earnings per share to witness 10-13% average annual growth.
CIPositive Net Change AMNNegative Net Change IVANegative Net Change ELVNegative Net Change
medical
Implied Volatility Surging for BellRing Brands (BRBR) Stock Options
by Zacks Equity Research
Investors need to pay close attention to BellRing Brands (BRBR) stock based on the movements in the options market lately.
BRBRPositive Net Change
medical medical-devices
3 Medical Instruments Stocks With Potential to Outperform
by Indrajit Bandyopadhyay
Here we discuss ShockWave Medical (SWAV), iRadimed (IRMD) and Tactile Systems Technology (TCMD), which have the potential to outperform their industry going forward.
IRMDNegative Net Change TCMDNegative Net Change SWAVNegative Net Change
medical medical-devices
Zacks.com featured highlights include Crocs, Unum Group, QuidelOrtho, LPL Financial Holdings and Clean Harbors
by Zacks Equity Research
Crocs, Unum Group, QuidelOrtho, LPL Financial Holdings and Clean Harbors are part of the Zacks Screen of the Week article.
UNMNegative Net Change CROXPositive Net Change QDELPositive Net Change CLHPositive Net Change LPLANegative Net Change
business-services consumer-discretionary finance insurance medical
New Strong Buy Stocks for November 28th
by Zacks Equity Research
KMDA, SLCA and FTNT have been added to the Zacks Rank #1 (Strong Buy) List on November 28, 2022.
FTNTNegative Net Change SLCANegative Net Change KMDAPositive Net Change
medical
Beat the Market the Zacks Way: Tenaris, Lululemon, AutoZone in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
AMGNNegative Net Change DGXNegative Net Change PACPositive Net Change ANegative Net Change TSCOPositive Net Change AZOPositive Net Change LULUPositive Net Change TSPositive Net Change NOBLNegative Net Change INSWNegative Net Change CALBPositive Net Change
finance medical